Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA
Clinical trial NCT03148860 · COMPLETED
Trial details
- NCT number
- NCT03148860
- Sponsor
- Dr. Frank Behrens
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-15
- Primary completion
- 2021-04-12
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.